Ursprung des Netzwerks ersten Grades von Sunil Joshi
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 21 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Sunil Joshi
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CARDINAL HEALTH, INC. | Medical Distributors | Director of Finance/CFO Public Communications Contact | |
| CELGENE | Biotechnology | Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ORTHOFIX MEDICAL INC. | Medical Specialties | Director/Board Member | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member | |
| DURECT CORPORATION | Pharmaceuticals: Major | Consultant / Advisor Public Communications Contact | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| COMPUGEN LTD. | Biotechnology | Director/Board Member | |
| NUVASIVE, INC. | Medical Specialties | Human Resources Officer | |
| Aventis, Inc. | Chief Tech/Sci/R&D Officer | ||
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| CAREFUSION CORPORATION | Medical Distributors | Investor Relations Contact Human Resources Officer | |
| TURG POIN | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| Stanford University | College/University | Graduate Degree Undergraduate Degree | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
| MIRATI THERAPEUTICS | Biotechnology | Human Resources Officer Director of Finance/CFO | |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Director/Board Member | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Undergraduate Degree | |
| University of California San Diego | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
| Sanofi-Aventis Pharmaceuticals | Corporate Officer/Principal | ||
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Synergie Lyon Cancer
 Synergie Lyon Cancer Miscellaneous Commercial ServicesCommercial Services Synergie Lyon Cancer provides health care services. It focuses on research efforts on cancer escape, apoptosis and senescence and Immune surveillance. The company was founded in 2007 and is headquartered in Lyon, France. | Miscellaneous Commercial Services | President | |
| European Organisation for Research & Treatment of Cancer | Director/Board Member | ||
International Drug Development Institute SA
 International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director/Board Member | |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
NuMedii, Inc.
 NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Tufts University School of Medicine | College/University | Doctorate Degree | |
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Institut de Recherches Internationales Servier
 Institut de Recherches Internationales Servier Miscellaneous Commercial ServicesCommercial Services Part of Servier SAS, Institut de Recherches Internationales Servier is a French company that provides scientific research and development services. The company is based in Suresnes, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
NETRIS Pharma SAS
 NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | Biotechnology | Chairman | |
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member | |
| APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Chairman | |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company based in San Diego, CA. Capstan Therapeutics aims to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies. The company's platform technology, TLNPs, is designed to deliver payloads and gene editing tools to reprogram specific cell types in vivo. This technology has the potential to generate transformative therapies for various disease areas, including autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. Capstan Therapeutics, Inc. was founded in 2022 by Haig Aghajanian. Laura K. Shawver has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Chairman | |
Leal Therapeutics, Inc.
 Leal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Leal Therapeutics, Inc. develops novel therapeutics for patients with major disorders of the central nervous systems. | Miscellaneous Commercial Services | Director/Board Member | |
Avenzo Therapeutics, Inc.
 Avenzo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avenzo Therapeutics, Inc. is a biotechnology company that operates in the field of therapeutics. The company is based in San Diego, CA. The company was founded by Mohammad Hirmand and the CEO is Athena M. Countouriotis. | Miscellaneous Commercial Services | Chief Executive Officer | |
Theravectys SAS
 Theravectys SAS BiotechnologyHealth Technology Theravectys SAS provides biotechnology research services. It is working on the development of a therapeutic vaccine against HIV. The company was founded on May 17, 2005 and is headquartered in Paris, France. | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 38 |
| Frankreich | 7 |
| Belgien | 4 |
| Israel | 2 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 31 |
| Commercial Services | 9 |
| Consumer Services | 6 |
| Distribution Services | 3 |
| Process Industries | 3 |
Operativ
| Director/Board Member | 69 |
| Corporate Officer/Principal | 45 |
| Independent Dir/Board Member | 33 |
| Undergraduate Degree | 16 |
| Chief Tech/Sci/R&D Officer | 15 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jean Bizzari | 24 |
| Jeffrey Henderson | 18 |
| Athena Countouriotis | 17 |
| James Daly | 13 |
| Laurie Stelzer | 13 |
| Jean Liu | 13 |
| Robert Engler | 13 |
| David Ramsay | 13 |
| Harry Leonhardt | 12 |
| John Stuart Patton | 12 |
| Michael Paolucci | 10 |
| Schond Greenway | 8 |
| Jim Mazzola | 6 |
| Homa Yeganegi | 6 |
| Douglas B. Muchmore | 5 |
- Börse
- Insiders
- Sunil Joshi
- Unternehmensverbindungen
